2030 年尿道结石管理设备市场预测：按产品、最终用户和地区分類的全球分析

根据 Stratistics MRC 的数据，2023 年全球尿道结石管理设备市场规模为 16.8 亿美元，预计在预测期内将以 6.9% 的复合年增长率成长，到 2030 年达到 26.9 亿美元。

尿道结石是指泌尿器官系统中结石的形成。尿道结石管理设备是用于诊断、治疗和管理尿道结石（包括肾结石和尿路结石）的专用工具和设备。这些设备在微创治疗、减少患者不适、缩短復原时间和改善尿道结石患者的治疗效果方面发挥着重要作用。

根据欧洲泌尿系统协会的数据，尿道结石的盛行率在 1% 至 20% 之间。肾结石在加拿大、瑞典和美国等已开发国家相当常见（超过10%）。

尿道结石盛行率上升

尿道结石盛行率的上升，以全球肾结石和尿道结石发生率的上升为标誌，是尿道结石治疗设备市场的关键驱动因素。生活型态改变、饮食习惯和水分不足等因素会导致尿道结石发生率增加。此类病例的快速增加需要有效的管理和治疗，从而刺激了对尿路结石治疗设备的需求。随着结石盛行率的不断增加，对碎石碾碎、输尿管镜和取石工具等先进设备的需求不断增加，创新的解决方案正在推动市场发展。

治疗费用高

与尿道结石治疗相关的费用（包括外科手术、医疗设备和后续护理）可能很高。这些高昂的费用限制了获得先进治疗方法和医疗设备的机会，特别是对于无力负担或保险范围不足的患者而言。经济负担阻碍人们选择先进的治疗方法，影响其采用，并阻碍市场成长。

对微创治疗的需求不断增长

与传统手术方法相比，微创治疗有术后疼痛减轻、住院时间短、恢復时间短、併发症风险低等优点，越来越受到病患的青睐。这一趋势导致对支持输尿管镜、雷射碾碎和衝击波碾碎等微创技术的尿道结石治疗设备的需求激增。此外，这些设备可以精确瞄准结石，同时最大限度地减少对周围组织的创伤。因此，市场成长的需求日益增加。

感染的风险

使用输尿管支架和碾碎等尿道结石结石治疗设备进行侵入性手术会增加感染的可能性。器械消毒不充分、器械保留时间过长、重复干预等都可能导致尿道感染和全身性感染疾病。这些感染疾病会导致併发症、延长住院时间、需要额外治疗并影响患者的健康结果。结果，阻碍了市场需求。

COVID-19 的影响

COVID-19 大流行造成了分销管道的中断以及对企业和金融市场的财务影响。停电迫使多家小型医院和老年住宅暂时关闭。此外，门诊预约被推迟，电话和虚拟咨询的需求增加。麻醉和治疗计划、病床和医务人员的缺乏导致治疗严重延误，对全球尿道结石管理设备市场产生了负面影响。

输尿管镜细分市场预计将成为预测期内最大的细分市场

输尿管内视镜检查部分估计占最大份额。输尿管镜由配备小型摄影机和光纤技术的柔性或半刚性仪器组成，使泌尿系统能够可视化并接近输尿管或肾臟内的结石。输尿管内的精确导航可实现碾碎、取石和雷射碾碎等手术。此外，输尿管镜在微创介入中发挥关键作用，减少患者不适，缩短復原时间，有助于有效的结石管理，从而帮助治疗尿道结石，正在形成前景。

在预测期内，医院领域的复合年增长率最高。

预计医院业务在预测期内将出现良好成长。该医院是尿道结石例诊断、治疗和管理的主要中心。这些设施利用各种尿道结石管理设备，包括碎石机、输尿管镜、结石取出设备、支架和诊断影像设备。该医院为尿道结石患者提供全面的泌尿系统手术和住院和门诊服务。此细分市场涵盖各种医院环境，从大型学术医疗中心到小型社区医院，所有这些医院都采用和利用尿道结石管理设备来追求有效的患者照护。

比最大的地区

由于尿道结石盛行率上升、医疗保健支出增加、技术进步和老年人口增加，亚太地区在估计期间占据了最大的市场占有率。此外，医疗基础设施的改善、医疗设施的普及以及对尿道结石治疗方案的认识提高，都刺激了这些设备的采用。亚太市场为寻求满足该地区尿道结石患者不断变化的需求的製造商和供应商提供了利润丰厚的机会。

复合年增长率最高的地区：

由于对微创治疗的偏好、强劲的研发活动和有利的报销政策，预计北美在预测期内将出现盈利成长。该地区包括美国和加拿大，拥有强大的医疗基础设施、高昂的医疗成本以及对泌尿系统创新的高度重视。此外，越来越重视以患者为中心的护理和技术进步，以及主要市场参与者的存在，使北美成为尖端尿道结石治疗解决方案的领先中心。

免费客製化服务

订阅此报告的客户可以存取以下免费自订选项之一：

• 公司简介
  • 其他市场参与者的综合分析（最多 3 家公司）
  • 主要企业SWOT分析（最多3家企业）
• 区域分割
  • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
• 竞争基准化分析
  • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

• 概述
• 相关利益者
• 调查范围
• 调查方法
  • 资料探勘
  • 资料分析
  • 资料检验
  • 研究途径
• 调查来源
  • 主要调查来源
  • 二次调查来源
  • 先决条件

第三章市场趋势分析

• 促进因素
• 抑制因素
• 机会
• 威胁
• 产品分析
• 最终用户分析
• 新兴市场
• 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

• 供应商的议价能力
• 买方议价能力
• 替代品的威胁
• 新进入者的威胁
• 竞争公司之间的敌对关係

第五章全球尿道结石治疗设备市场：依产品

• 震波碎石机
  • 体内
    • 超音波
    • 雷射
    • 空气压力
  • 体外
• 输尿管肾镜
  • 死板的
  • 灵活的
  • 半刚性

第六章全球尿道结石疾病管理设备市场：依最终用户分类

• 诊所及门诊治疗中心
• 医院
• 其他最终用户

第七章全球尿道结石结石治疗设备市场：按地区

• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 义大利
  • 法国
  • 西班牙
  • 其他欧洲国家
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 纽西兰
  • 韩国
  • 其他亚太地区
• 南美洲
  • 阿根廷
  • 巴西
  • 智利
  • 南美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 卡达
  • 南非
  • 其他中东和非洲

第八章 主要进展

• 合约、伙伴关係、协作和合资企业
• 收购和合併
• 新产品发布
• 业务扩展
• 其他关键策略

第九章 公司简介

• Olympus
• Boston Scientific
• Karl Storz
• Siemens Medical Solutions
• Richard Wolf
• Cook Medical
• Dornier
• Elmed
• MTS Medical
• Direxgroup
• Cybersonics
• Allengers
• BD
• DirexGroup
• CONMED Corporation
• Potent Medical
• HealthTronics, Inc

According to Stratistics MRC, the Global Urolithiasis Management Devices Market is accounted for $1.68 billion in 2023 and is expected to reach $2.69 billion by 2030 growing at a CAGR of 6.9% during the forecast period. Urolithiasis refers to the development of stones in the urinary system. Urolithiasis Management Devices are specialized tools and equipment used in the diagnosis, treatment, and management of urinary stones, including kidney stones and stones within the urinary tract. These devices play a crucial role in minimally invasive treatments, reducing patient discomfort, shortening recovery times, and improving outcomes for individuals suffering from urolithiasis.

According to the European Association of Urology, the prevalence of urinary stones ranges from 1% up to 20%. Renal stones are substantially more common (>10%) in developed nations like Canada, Sweden, and the U.S.

Market Dynamics:

Driver:

Rising prevalence of urolithiasis

The escalating prevalence of urolithiasis, characterised by a rising incidence of kidney stones and urinary tract stones worldwide, serves as a significant driver in the Urolithiasis Management Devices Market. Lifestyle changes, dietary habits, and factors like inadequate hydration contribute to the increased occurrence of urolithiasis. This surge in cases necessitates effective management and treatment, fuelling the demand for urolithiasis management devices. As the prevalence continues to grow, there is a heightened need for advanced devices such as lithotripters, ureteroscopes, and stone retrieval tools, driving the market towards innovative solutions.

Restraint:

High treatment costs

The expenses associated with urolithiasis management, including surgical procedures, medical devices, and follow-up care, can be substantial. These high costs limit accessibility to advanced treatments and devices, particularly for patients with limited financial means or inadequate insurance coverage. The financial burden discourages some individuals from opting for advanced procedures, impacting their adoption and hindering market growth.

Opportunity:

Growing demand for minimally invasive procedures

Patients increasingly prefer minimally invasive treatments due to several advantages, including reduced post-operative pain, shorter hospital stays, quicker recovery times, and a lower risk of complications compared to traditional surgical methods. This trend has surged the demand for urolithiasis management devices that support minimally invasive techniques such as ureteroscopy, laser lithotripsy, and shockwave lithotripsy. Additionally, these devices enable precise targeting of stones while minimising trauma to surrounding tissues. Thus, there is an increasing demand for market growth.

Threat:

Risk of infection

Invasive procedures involving urolithiasis management devices, such as ureteral stents or lithotripsy tools, increase the susceptibility to infections. Improperly sterilised equipment, prolonged device placement, or repeated interventions may lead to urinary tract infections or systemic infections. These infections can cause complications, prolong hospital stays, and necessitate additional treatments, impacting patient health outcomes. As a result, it will hinder market demand.

Covid-19 Impact

The COVID-19 pandemic is causing disruptions in distribution channels and through its financial impact on firms and financial markets. Due to obstacles, various small hospitals and elderly housing units had to be temporarily closed. Additionally, there was a delay in the scheduling of appointments for outpatient clinics, which increased the demand for phone or virtual clinics. The absence of anaesthesia or procedural slots, in-hospital beds, and medical personnel resulted in a major treatment backlog, which had a negative impact on the worldwide urolithiasis management device market.

The ureterorenoscopes segment is expected to be the largest during the forecast period

The ureterorenoscopes segment is estimated to hold the largest share. Ureterorenoscopes consist of flexible or semi-rigid instruments equipped with miniature cameras and fibre-optic technology, allowing urologists to visualise and access stones in the ureter or kidney. They facilitate precise navigation through the urinary tract, enabling procedures like stone fragmentation, retrieval, or laser lithotripsy. Furthermore, ureterorenoscopes play a pivotal role in less invasive interventions, reducing patient discomfort, shortening recovery times, and contributing to effective stone management, thereby shaping the landscape of urolithiasis treatment.

The hospitals segment is expected to have the highest CAGR during the forecast period

The hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals serve as primary centres for the diagnosis, treatment, and management of urolithiasis cases. Within these facilities, various urolithiasis management devices are utilized, including lithotripters, ureteroscopes, stone retrieval tools, stents, and imaging modalities. Hospitals provide a comprehensive range of urological procedures and surgeries, offering both inpatient and outpatient services for urolithiasis patients. The segment encompasses diverse hospital settings, from large academic medical centres to smaller community hospitals, all contributing to the adoption and utilisation of urolithiasis management devices in the quest for effective patient care.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the rising prevalence of urolithiasis, increasing healthcare expenditure, technological advancements, and a growing geriatric population. Moreover, improving healthcare infrastructure, greater accessibility to medical facilities, and expanding awareness about urolithiasis treatment options fuel the adoption of these devices. The Asia-Pacific market presents lucrative opportunities for manufacturers and providers aiming to cater to the evolving needs of urolithiasis patients in the region.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period due to preference for minimally invasive procedures, strong research and development activities, and favourable reimbursement policies. The region, encompassing the United States and Canada, boasts a robust healthcare infrastructure, high healthcare expenditures, and a significant focus on technological innovations in urology. Moreover, the presence of key market players, along with a growing emphasis on patient-centric care and technological advancements, positions North America as a leading hub for cutting-edge urolithiasis treatment solutions.

Key players in the market

Some of the key players in the Urolithiasis Management Devices Market include Olympus, Boston Scientific, Karl Storz, Siemens Medical Solutions, Richard Wolf, Cook Medical, Dornier, Elmed, MTS Medical, Direxgroup, Cybersonics, Allengers, BD, DirexGroup, CONMED Corporation, Potent Medical , and HealthTronics, Inc.

Key Developments:

In July 2022, Calyxo announced the successful closure of its Series C investment round, securing USD 32.7 million. Based in California, Calyxo has developed the CVAC Aspiration system, designed to eliminate kidney stones without the need for surgery, utilizing irrigation and aspiration methods.

In March 2022, The FDA recognized Applaud Medical's Acoustic Enhancer technology as a breakthrough product. It is designed to break down calcium-based urinary stones that are obstructing or pose a significant risk of future hindrance, provided they are between 6mm and 20 mm in diameter.

Products Covered:

• Shock Wave Lithotripters
• Ureterorenoscopes

End Users Covered:

• Clinics and Ambulatory Care Centers
• Hospitals
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 End User Analysis
• 3.8 Emerging Markets
• 3.9 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Urolithiasis Management Devices Market, By Product

• 5.1 Introduction
• 5.2 Shock Wave Lithotripters
  • 5.2.1 Intracorporeal
    • 5.2.1.1 Ultrasound
    • 5.2.1.2 Laser
    • 5.2.1.3 Pneumatic
  • 5.2.2 Extracorporea
• 5.3 Ureterorenoscopes
  • 5.3.1 Rigid
  • 5.3.2 Flexible
  • 5.3.3 Semi Rigid

6 Global Urolithiasis Management Devices Market, By End User

• 6.1 Introduction
• 6.2 Clinics and Ambulatory Care Centers
• 6.3 Hospitals
• 6.4 Other End Users

7 Global Urolithiasis Management Devices Market, By Geography

• 7.1 Introduction
• 7.2 North America
  • 7.2.1 US
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 Italy
  • 7.3.4 France
  • 7.3.5 Spain
  • 7.3.6 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 Japan
  • 7.4.2 China
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 New Zealand
  • 7.4.6 South Korea
  • 7.4.7 Rest of Asia Pacific
• 7.5 South America
  • 7.5.1 Argentina
  • 7.5.2 Brazil
  • 7.5.3 Chile
  • 7.5.4 Rest of South America
• 7.6 Middle East & Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 UAE
  • 7.6.3 Qatar
  • 7.6.4 South Africa
  • 7.6.5 Rest of Middle East & Africa

8 Key Developments

• 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 8.2 Acquisitions & Mergers
• 8.3 New Product Launch
• 8.4 Expansions
• 8.5 Other Key Strategies

9 Company Profiling

• 9.1 Olympus
• 9.2 Boston Scientific
• 9.3 Karl Storz
• 9.4 Siemens Medical Solutions
• 9.5 Richard Wolf
• 9.6 Cook Medical
• 9.7 Dornier
• 9.8 Elmed
• 9.9 MTS Medical
• 9.10 Direxgroup
• 9.11 Cybersonics
• 9.12 Allengers
• 9.13 BD
• 9.14 DirexGroup
• 9.15 CONMED Corporation
• 9.16 Potent Medical
• 9.17 HealthTronics, Inc

List of Tables

• Table 1 Global Urolithiasis Management Devices Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 4 Global Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 5 Global Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 6 Global Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 7 Global Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 8 Global Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 9 Global Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 10 Global Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 11 Global Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 12 Global Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 13 Global Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 14 North America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 15 North America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 16 North America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 17 North America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 18 North America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 19 North America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 20 North America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 21 North America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 22 North America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 23 North America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 24 North America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 25 North America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 26 North America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 27 Europe Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 28 Europe Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 29 Europe Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 30 Europe Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 31 Europe Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 32 Europe Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 33 Europe Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 34 Europe Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 35 Europe Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 36 Europe Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 37 Europe Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 38 Europe Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 39 Europe Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 40 Asia Pacific Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 41 Asia Pacific Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 42 Asia Pacific Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 43 Asia Pacific Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 44 Asia Pacific Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 45 Asia Pacific Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 46 Asia Pacific Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 47 Asia Pacific Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 48 Asia Pacific Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 49 Asia Pacific Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 50 Asia Pacific Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 51 Asia Pacific Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 52 Asia Pacific Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 53 South America Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 54 South America Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 55 South America Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 56 South America Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 57 South America Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 58 South America Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 59 South America Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 60 South America Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 61 South America Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 62 South America Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 63 South America Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 64 South America Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 65 South America Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)
• Table 66 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Country (2021-2030) ($MN)
• Table 67 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Product (2021-2030) ($MN)
• Table 68 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Shock Wave Lithotripters (2021-2030) ($MN)
• Table 69 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Intracorporeal (2021-2030) ($MN)
• Table 70 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Extracorporea (2021-2030) ($MN)
• Table 71 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Ureterorenoscopes (2021-2030) ($MN)
• Table 72 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Rigid (2021-2030) ($MN)
• Table 73 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Flexible (2021-2030) ($MN)
• Table 74 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Semi Rigid (2021-2030) ($MN)
• Table 75 Middle East & Africa Urolithiasis Management Devices Market Outlook, By End User (2021-2030) ($MN)
• Table 76 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Clinics and Ambulatory Care Centers (2021-2030) ($MN)
• Table 77 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 78 Middle East & Africa Urolithiasis Management Devices Market Outlook, By Other End Users (2021-2030) ($MN)